MELISSA FRANK: Open Payments
NPI 1487868782 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,010 in 103 payments from 27 companies in 2025. Trend: 2023 $1,942 · 2024 $1,926 · 2025 $2,010
Food & beverage: $2,010
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $351 |
| PFIZER INC. | 11 | $202 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| Amgen Inc. | 9 | $139 |
| GlaxoSmithKline, LLC. | 7 | $137 |
| Lilly USA, LLC | 5 | $97 |
| SANOFI-AVENTIS U.S. LLC | 3 | $93 |
| Eisai Inc. | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $81 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
Products named: Ozempic, BREZTRI, TZIELD, Leqembi, Kerendia, NURTEC ODT, LEQVIO, JARDIANCE.
Industry payments across FL — which companies pay providers there.
